Clinical Trial Update: Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients [NA]

View source ↗

Summary

Clinical trial update comparing renal protective effects of febuxostat versus benzbromarone in Chinese patients with chronic kidney disease and hyperuricemia; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperuricemia

Drugs mentioned

• Uloric (febuxostat)
• benzbromarone (benzbromarone)

Snippet

Sponsor: Shanghai 10th People's Hospital | Conditions: Chronic Kidney Disease, Hyperuricemia | NA | Status: UNKNOWN